North American Thrombosis Forum, AF Action Initiative Consensus Document

Christian T. Ruff; Jack E. Ansell; Richard C. Becker; Emelia J. Benjamin; David J. Deicicchi; N. A. Mark Estes; Michael D. Ezekowitz; John Fanikos; Jawed Fareed; David Garcia; Robert P. Giugliano; Samuel Z. Goldhaber; Christopher Granger; Jeff S. Healey; Russell Hull; Elaine M. Hylek; Peter Libby; Renato D. Lopes; Kenneth W. Mahaffey; Jessica Mega; Gregory Piazza; Arthur A. Sasahara; Farzaneh A. Sorond; Alex C. Spyropoulos; Jeanine M. Walenga; Jeffrey I. Weitz

doi:10.1016/j.amjmed.2016.02.001

North American Thrombosis Forum, AF Action Initiative Consensus Document

Christian T. Ruff^*, Jack E. Ansell, Richard C. Becker, Emelia J. Benjamin, David J. Deicicchi, N. A. Mark Estes, Michael D. Ezekowitz, John Fanikos, Jawed Fareed, David Garcia, Robert P. Giugliano, Samuel Z. Goldhaber, Christopher Granger, Jeff S. Healey, Russell Hull, Elaine M. Hylek, Peter Libby, Renato D. Lopes, Kenneth W. Mahaffey, Jessica MegaGregory Piazza, Arthur A. Sasahara, Farzaneh A. Sorond, Alex C. Spyropoulos, Jeanine M. Walenga, Jeffrey I. Weitz

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

The North American Thrombosis Forum Atrial Fibrillation Action Initiative consensus document is a comprehensive yet practical briefing document focusing on stroke and bleeding risk assessment in patients with atrial fibrillation, as well as recommendations regarding anticoagulation options and management. Despite the breadth of clinical trial data and guideline recommendation updates, many clinicians continue to struggle to synthesize the disparate information available. This problem slows the uptake and utilization of updated risk prediction tools and adoption of new oral anticoagulants. This document serves as a practical and educational reference for the entire medical community involved in the care of patients with atrial fibrillation.

Original language	English (US)
Pages (from-to)	S1-S29
Journal	American Journal of Medicine
Volume	129
Issue number	5
DOIs	https://doi.org/10.1016/j.amjmed.2016.02.001
State	Published - May 1 2016

Keywords

Anticoagulants
Antithrombotic management
Atrial fibrillation
Bleeding risk
Stroke

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/j.amjmed.2016.02.001

Cite this

Ruff, C. T., Ansell, J. E., Becker, R. C., Benjamin, E. J., Deicicchi, D. J., Mark Estes, N. A., Ezekowitz, M. D., Fanikos, J., Fareed, J., Garcia, D., Giugliano, R. P., Goldhaber, S. Z., Granger, C., Healey, J. S., Hull, R., Hylek, E. M., Libby, P., Lopes, R. D., Mahaffey, K. W., ... Weitz, J. I. (2016). North American Thrombosis Forum, AF Action Initiative Consensus Document. American Journal of Medicine, 129(5), S1-S29. https://doi.org/10.1016/j.amjmed.2016.02.001

@article{1410ef41031947f3b6a389d41e24b1ee,

title = "North American Thrombosis Forum, AF Action Initiative Consensus Document",

abstract = "The North American Thrombosis Forum Atrial Fibrillation Action Initiative consensus document is a comprehensive yet practical briefing document focusing on stroke and bleeding risk assessment in patients with atrial fibrillation, as well as recommendations regarding anticoagulation options and management. Despite the breadth of clinical trial data and guideline recommendation updates, many clinicians continue to struggle to synthesize the disparate information available. This problem slows the uptake and utilization of updated risk prediction tools and adoption of new oral anticoagulants. This document serves as a practical and educational reference for the entire medical community involved in the care of patients with atrial fibrillation.",

keywords = "Anticoagulants, Antithrombotic management, Atrial fibrillation, Bleeding risk, Stroke",

author = "Ruff, {Christian T.} and Ansell, {Jack E.} and Becker, {Richard C.} and Benjamin, {Emelia J.} and Deicicchi, {David J.} and {Mark Estes}, {N. A.} and Ezekowitz, {Michael D.} and John Fanikos and Jawed Fareed and David Garcia and Giugliano, {Robert P.} and Goldhaber, {Samuel Z.} and Christopher Granger and Healey, {Jeff S.} and Russell Hull and Hylek, {Elaine M.} and Peter Libby and Lopes, {Renato D.} and Mahaffey, {Kenneth W.} and Jessica Mega and Gregory Piazza and Sasahara, {Arthur A.} and Sorond, {Farzaneh A.} and Spyropoulos, {Alex C.} and Walenga, {Jeanine M.} and Weitz, {Jeffrey I.}",

note = "Funding Information: Funding: This supplement was made possible by generous support from Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, and Janssen Pharmaceuticals. Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = may,

day = "1",

doi = "10.1016/j.amjmed.2016.02.001",

language = "English (US)",

volume = "129",

pages = "S1--S29",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "5",

}

Ruff, CT, Ansell, JE, Becker, RC, Benjamin, EJ, Deicicchi, DJ, Mark Estes, NA, Ezekowitz, MD, Fanikos, J, Fareed, J, Garcia, D, Giugliano, RP, Goldhaber, SZ, Granger, C, Healey, JS, Hull, R, Hylek, EM, Libby, P, Lopes, RD, Mahaffey, KW, Mega, J, Piazza, G, Sasahara, AA, Sorond, FA, Spyropoulos, AC, Walenga, JM & Weitz, JI 2016, 'North American Thrombosis Forum, AF Action Initiative Consensus Document', American Journal of Medicine, vol. 129, no. 5, pp. S1-S29. https://doi.org/10.1016/j.amjmed.2016.02.001

TY - JOUR

T1 - North American Thrombosis Forum, AF Action Initiative Consensus Document

AU - Ruff, Christian T.

AU - Ansell, Jack E.

AU - Becker, Richard C.

AU - Benjamin, Emelia J.

AU - Deicicchi, David J.

AU - Mark Estes, N. A.

AU - Ezekowitz, Michael D.

AU - Fanikos, John

AU - Fareed, Jawed

AU - Garcia, David

AU - Giugliano, Robert P.

AU - Goldhaber, Samuel Z.

AU - Granger, Christopher

AU - Healey, Jeff S.

AU - Hull, Russell

AU - Hylek, Elaine M.

AU - Libby, Peter

AU - Lopes, Renato D.

AU - Mahaffey, Kenneth W.

AU - Mega, Jessica

AU - Piazza, Gregory

AU - Sasahara, Arthur A.

AU - Sorond, Farzaneh A.

AU - Spyropoulos, Alex C.

AU - Walenga, Jeanine M.

AU - Weitz, Jeffrey I.

N1 - Funding Information: Funding: This supplement was made possible by generous support from Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, and Janssen Pharmaceuticals. Publisher Copyright: © 2016 Elsevier Inc.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - The North American Thrombosis Forum Atrial Fibrillation Action Initiative consensus document is a comprehensive yet practical briefing document focusing on stroke and bleeding risk assessment in patients with atrial fibrillation, as well as recommendations regarding anticoagulation options and management. Despite the breadth of clinical trial data and guideline recommendation updates, many clinicians continue to struggle to synthesize the disparate information available. This problem slows the uptake and utilization of updated risk prediction tools and adoption of new oral anticoagulants. This document serves as a practical and educational reference for the entire medical community involved in the care of patients with atrial fibrillation.

AB - The North American Thrombosis Forum Atrial Fibrillation Action Initiative consensus document is a comprehensive yet practical briefing document focusing on stroke and bleeding risk assessment in patients with atrial fibrillation, as well as recommendations regarding anticoagulation options and management. Despite the breadth of clinical trial data and guideline recommendation updates, many clinicians continue to struggle to synthesize the disparate information available. This problem slows the uptake and utilization of updated risk prediction tools and adoption of new oral anticoagulants. This document serves as a practical and educational reference for the entire medical community involved in the care of patients with atrial fibrillation.

KW - Anticoagulants

KW - Antithrombotic management

KW - Atrial fibrillation

KW - Bleeding risk

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84965127896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965127896&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2016.02.001

DO - 10.1016/j.amjmed.2016.02.001

M3 - Article

C2 - 27126598

AN - SCOPUS:84965127896

SN - 0002-9343

VL - 129

SP - S1-S29

JO - American Journal of Medicine

JF - American Journal of Medicine

IS - 5

ER -

North American Thrombosis Forum, AF Action Initiative Consensus Document

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this